MicroRNA-383 suppresses cell proliferation and invasion in colorectal cancer by directly targeting paired box 6 Retraction in /10.3892/mmr.2023.13055

Yan,Fei; Tu,Zhiquan; Duan,Li; Wang ,Dexing; Lin,Feng

doi:10.3892/mmr.2018.8682

MicroRNA-383 suppresses cell proliferation and invasion in colorectal cancer by directly targeting paired box 6

Retraction in: /10.3892/mmr.2023.13055

Authors:
- Fei Yan
- Zhiquan Tu
- Li Duan
- Dexing Wang
- Feng Lin
View Affiliations

Affiliations: Department of Oncology, The Eighth People's Hospital of Shanghai, Shanghai 200233, P.R. China
Published online on: March 6, 2018 https://doi.org/10.3892/mmr.2018.8682
Pages: 6893-6901

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Colorectal cancer (CRC) is the third-most prevalent cancer and the fourth‑most common cause of cancer-associated fatality worldwide. The expression and biological roles of microRNAs (miRNAs/miRs) in tumourigenesis, and their regulatory function in a number of biological processes correlated with cancer have been investigated. miR‑383 has been reported to be deregulated in several human cancer types. However, the involvement and effects of miR‑383 on CRC progression and its underlying mechanism remain unknown. Therefore, the present study aimed to examine miR‑383 expression, investigate the biological functions of miR‑383 and identify its mechanism of action in CRC cells. In the present study, miR‑383 was significantly downregulated in CRC tissues and cell lines. Low miR‑383 expression was negatively associated with tumour size, lymph node metastasis and TNM stage. Function experiments demonstrated that miR‑383 upregulation inhibited the proliferation and invasion of CRC cells. Paired box 6 (PAX6) was confirmed as a direct target of miR‑383. PAX6 was upregulated in CRC tissues and was negatively correlated with miR‑383 expression. Induced PAX6 overexpression effectively rescued the tumour‑suppressing roles of miR‑383 on CRC cell proliferation and invasion. These findings suggested that miR‑383 may act as a tumour suppressor in CRC by directly targeting PAX6 and may serve as a promising therapeutic target for CRC treatment.

View Figures

View References

1	Jemal A, Siegel R, Xu J and Ward E: Cancer statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
2	Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015. View Article : Google Scholar : PubMed/NCBI
3	Zhang YL, Zhang ZS, Wu BP and Zhou DY: Early diagnosis for colorectal cancer in China. World J Gastroenterol. 8:21–25. 2002. View Article : Google Scholar : PubMed/NCBI
4	Andrews L: Dietary flavonoids for the prevention of colorectal cancer. Clin J Oncol Nurs. 17:671–672. 2013. View Article : Google Scholar : PubMed/NCBI
5	Altobelli E, Lattanzi A, Paduano R, Varassi G and di Orio F: Colorectal cancer prevention in Europe: Burden of disease and status of screening programs. Prev Med. 62:132–141. 2014. View Article : Google Scholar : PubMed/NCBI
6	Sugarbaker PH: Colorectal cancer: Prevention and management of metastatic disease. Biomed Res Int. 2014:7828902014. View Article : Google Scholar : PubMed/NCBI
7	Chan DS, Lau R, Aune D, Vieira R, Greenwood DC, Kampman E and Norat T: Red and processed meat and colorectal cancer incidence: Meta-analysis of prospective studies. PLoS One. 6:e204562011. View Article : Google Scholar : PubMed/NCBI
8	Lech G, Slotwinski R, Slodkowski M and Krasnodebski IW: Colorectal cancer tumour markers and biomarkers: Recent therapeutic advances. World J Gastroenterol. 22:1745–1755. 2016. View Article : Google Scholar : PubMed/NCBI
9	Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J and Bouvier AM: Epidemiology and management of liver metastases from colorectal cancer. Ann Surg. 244:254–259. 2006. View Article : Google Scholar : PubMed/NCBI
10	Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell. 116:281–297. 2004. View Article : Google Scholar : PubMed/NCBI
11	Karp X and Ambros V: Developmental biology. Encountering microRNAs in cell fate signaling. Science. 310:1288–1289. 2005. View Article : Google Scholar : PubMed/NCBI
12	Namlos HM, Meza-Zepeda LA, Barøy T, Østensen IH, Kresse SH, Kuijjer ML, Serra M, Bürger H, Cleton-Jansen AM and Myklebost O: Modulation of the osteosarcoma expression phenotype by microRNAs. PLoS One. 7:e480862012. View Article : Google Scholar : PubMed/NCBI
13	Pirola CJ, Gianotti TF, Castaño GO and Sookoian S: Circulating MicroRNA-122 signature in nonalcoholic fatty liver disease and cardiovascular disease: A new endocrine system in metabolic syndrome. Hepatology. 57:2545–2547. 2013. View Article : Google Scholar : PubMed/NCBI
14	Wang S, Wan X and Ruan Q: The MicroRNA-21 in autoimmune diseases. Int J Mol Sci. 17:E8642016. View Article : Google Scholar : PubMed/NCBI
15	Witwer KW, Sarbanes SL, Liu J and Clements JE: A plasma microRNA signature of acute lentiviral infection: Biomarkers of central nervous system disease. AIDS. 25:2057–2067. 2011. View Article : Google Scholar : PubMed/NCBI
16	Lubezky N, Loewenstein S, Ben-Haim M, Brazowski E, Marmor S, Pasmanik-Chor M, Oron-Karni V, Rechavi G, Klausner JM and Lahat G: MicroRNA expression signatures in intraductal papillary mucinous neoplasm of the pancreas. Surgery. 153:663–672. 2013. View Article : Google Scholar : PubMed/NCBI
17	Bhaumik D, Scott GK, Schokrpur S, Patil CK, Campisi J and Benz CC: Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells. Oncogene. 27:5643–5647. 2008. View Article : Google Scholar : PubMed/NCBI
18	Abella V, Valladares M, Rodriguez T, Haz M, Blanco M, Tarrio N, Iglesias P, Aparicio LA and Figueroa A: miR-203 regulates cell proliferation through its influence on Hakai expression. PLoS One. 7:e525682012. View Article : Google Scholar : PubMed/NCBI
19	Li J, Huang H, Sun L, Yang M, Pan C, Chen W, Wu D, Lin Z, Zeng C, Yao Y, et al: miR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor. Clin Cancer Res. 15:3998–4008. 2009. View Article : Google Scholar : PubMed/NCBI
20	Croce CM: Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet. 10:704–714. 2009. View Article : Google Scholar : PubMed/NCBI
21	Huang H, Tian H, Duan Z, Cao Y, Zhang XS and Sun F: microRNA-383 impairs phosphorylation of H2AX by targeting PNUTS and inducing cell cycle arrest in testicular embryonal carcinoma cells. Cell Signal. 26:903–911. 2014. View Article : Google Scholar : PubMed/NCBI
22	Han RL, Wang FP, Zhang PA, Zhou XY and Li Y: miR-383 inhibits ovarian cancer cell proliferation, invasion and aerobic glycolysis by targeting LDHA. Neoplasma. 64:244–252. 2017. View Article : Google Scholar : PubMed/NCBI
23	Azarbarzin S, Feizi MAH, Safaralizadeh R, Kazemzadeh M and Fateh A: The value of miR-383, an Intronic miRNA, as a diagnostic and prognostic biomarker in intestinal-type gastric cancer. Biochem Genet. 55:244–252. 2017. View Article : Google Scholar : PubMed/NCBI
24	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
25	Li Y, Li Y, Liu Y, Xie P, Li F and Li G: PAX6, a novel target of microRNA-7, promotes cellular proliferation and invasion in human colorectal cancer cells. Dig Dis Sci. 59:598–606. 2014. View Article : Google Scholar : PubMed/NCBI
26	Salem CE, Markl ID, Bender CM, Gonzales FA, Jones PA and Liang G: PAX6 methylation and ectopic expression in human tumor cells. Int J Cancer. 87:179–185. 2000. View Article : Google Scholar : PubMed/NCBI
27	Sun Y, Wang L, Guo SC, Wu XB and Xu XH: High-throughput sequencing to identify miRNA biomarkers in colorectal cancer patients. Oncol Lett. 8:711–713. 2014. View Article : Google Scholar : PubMed/NCBI
28	Huang N, Lin J, Ruan J, Su N, Qing R, Liu F, He B, Lv C, Zheng D and Luo R: miR-219-5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican-3. FEBS Lett. 586:884–891. 2012. View Article : Google Scholar : PubMed/NCBI
29	Esquela-Kerscher A and Slack FJ: Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006. View Article : Google Scholar : PubMed/NCBI
30	Sui GQ, Fei D, Guo F, Zhen X, Luo Q, Yin S and Wang H: MicroRNA-338-3p inhibits thyroid cancer progression through targeting AKT3. Am J Cancer Res. 7:1177–1187. 2017.PubMed/NCBI
31	Xu D, Ma P, Gao G, Gui Y, Niu X and Jin B: MicroRNA-383 expression regulates proliferation, migration, invasion and apoptosis in human glioma cells. Tumour Biol. 36:7743–7753. 2015. View Article : Google Scholar : PubMed/NCBI
32	Shang Y, Zang A, Li J, Jia Y, Li X, Zhang L, Huo R, Yang J, Feng J, Ge K, et al: MicroRNA-383 is a tumor suppressor and potential prognostic biomarker in human non-small cell lung caner. Biomed Pharmacother. 83:1175–1181. 2016. View Article : Google Scholar : PubMed/NCBI
33	Ma H, Liu B, Wang S and Liu J: MicroRNA-383 is a tumor suppressor in human lung cancer by targeting endothelial PAS domain-containing protein 1. Cell Biochem Funct. 34:613–619. 2016. View Article : Google Scholar : PubMed/NCBI
34	Fang Z, He L, Jia H, Huang Q, Chen D and Zhang Z: The miR-383-LDHA axis regulates cell proliferation, invasion and glycolysis in hepatocellular cancer. Iran J Basic Med Sci. 20:187–192. 2017.PubMed/NCBI
35	Zhao LN, Wang P, Liu YH, Cai H, Ma J, Liu LB, Xi Z, Li ZQ, Liu XB and Xue YX: miR-383 inhibits proliferation, migration and angiogenesis of glioma-exposed endothelial cells in vitro via VEGF-mediated FAK and Src signaling pathways. Cell Signal. 30:142–153. 2017. View Article : Google Scholar : PubMed/NCBI
36	Xu Z, Zeng X, Tian D, Xu H, Cai Q, Wang J and Chen Q: MicroRNA-383 inhibits anchorage-independent growth and induces cell cycle arrest of glioma cells by targeting CCND1. Biochem Biophys Res Commun. 453:833–838. 2014. View Article : Google Scholar : PubMed/NCBI
37	He Z, Cen D, Luo X, Li D, Li P, Liang L and Meng Z: Downregulation of miR-383 promotes glioma cell invasion by targeting insulin-like growth factor 1 receptor. Med Oncol. 30:5572013. View Article : Google Scholar : PubMed/NCBI
38	Li KK, Pang JC, Lau KM, Zhou L, Mao Y, Wang Y, Poon WS and Ng HK: miR-383 is downregulated in medulloblastoma and targets peroxiredoxin 3 (PRDX3). Brain Pathol. 23:413–425. 2013. View Article : Google Scholar : PubMed/NCBI
39	Yamaoka T and Itakura M: Development of pancreatic islets (Review). Int J Mol Med. 3:247–261. 1999.PubMed/NCBI
40	Elso C, Lu X, Weisner PA, Thompson HL, Skinner A, Carver E and Stubbs L: A reciprocal translocation dissects roles of Pax6 alternative promoters and upstream regulatory elements in the development of pancreas, brain and eye. Genesis. 51:630–646. 2013.PubMed/NCBI
41	Zhao Y, Lu G, Ke X, Lu X, Wang X, Li H, Ren M and He S: miR-488 acts as a tumor suppressor gene in gastric cancer. Tumour Biol. 37:8691–8698. 2016. View Article : Google Scholar : PubMed/NCBI
42	Luo J, Li H and Zhang C: MicroRNA-7 inhibits the malignant phenotypes of nonsmall cell lung cancer in vitro by targeting Pax6. Mol Med Rep. 12:5443–5448. 2015. View Article : Google Scholar : PubMed/NCBI
43	Xia X, Yin W, Zhang X, Yu X, Wang C, Xu S, Feng W and Yang H: PAX6 overexpression is associated with the poor prognosis of invasive ductal breast cancer. Oncol Lett. 10:1501–1506. 2015. View Article : Google Scholar : PubMed/NCBI
44	Bai SW, Li B, Zhang H, Jonas JB, Zhao BW, Shen L and Wang YC: Pax6 regulates proliferation and apoptosis of human retinoblastoma cells. Invest Ophthalmol Vis Sci. 52:4560–4570. 2011. View Article : Google Scholar : PubMed/NCBI
45	Huang BS, Luo QZ, Han Y, Li XB, Cao LJ and Wu LX: microRNA-223 promotes the growth and invasion of glioblastoma cells by targeting tumor suppressor PAX6. Oncol Rep. 30:2263–2269. 2013. View Article : Google Scholar : PubMed/NCBI
46	Zhou YH, Hu Y, Mayes D, Siegel E, Kim JG, Mathews MS, Hsu N, Eskander D, Yu O, Tromberg BJ and Linskey ME: PAX6 suppression of glioma angiogenesis and the expression of vascular endothelial growth factor A. J Neurooncol. 96:191–200. 2010. View Article : Google Scholar : PubMed/NCBI
47	Meng Y, Zou Q, Liu T, Cai X, Huang Y and Pan J: microRNA-335 inhibits proliferation, cell-cycle progression, colony formation and invasion via targeting PAX6 in breast cancer cells. Mol Med Rep. 11:379–385. 2015. View Article : Google Scholar : PubMed/NCBI